ScripsAmerica, Inc. (SCRC) staying focused on thes
Post# of 7769
Posted On: 01/17/2015 3:06:31 PM
Re: pipedream1 #6243
ScripsAmerica, Inc. (SCRC) staying focused on these fundamentals! Go SCRC! Tut
ScripsAmerica, Inc. is a supplier of prescription, Over-the-Counter (OTC), and nutraceutical drugs. The Tysons Corner, Virginia-based Company delivers pharmaceutical products to a wide assortment of end users across the health care industry by way of the largest pharmaceutical distributor in North America - McKesson Corp. End users include physicians' offices, retail pharmacies, long-term care sites, hospitals, and government and home care agencies. ScripsAmerica’s shares trade on the OTC Markets’ OTCQB.
The Company’s mission for consumers is to provide them the same high quality pharmaceutical, vitamin, and nutritional supplements that it supplies nationally to hospitals and nursing homes. It provides a strong low cost system of broad-based U.S. national marketing, sales, and distribution of generic Rx, branded Rx, OTC, nutraceuticals, and oral delivery OTC pharmaceuticals.
Regarding Pharmaceutical Contract Services, ScripsAmerica’s service offering includes fulfilling prescription and OTC orders, labeling, packaging, and shipping. Current therapeutic categories serviced by the Company include pain, arthritis, prenatal, urinary, and hormonal replacement drugs. The Company’s other customers include Cardinal Health, Curtis Pharmaceuticals, MedVet, as well as the United States Veterans Administration.
ScripsAmerica has its RapiMed® product line. RapiMed® is an inventive pharmaceutical and OTC oral delivery method employing “Quick Melt Technology”. RapiMed® oral tablets dissolve in 30 seconds or less. They provide fast delivery of medicine without water. ScripsAmerica holds the exclusive rights to RapiMed®.
Last month, ScripsAmerica announced that it recently acquired 100 percent of Main Avenue Pharmacy, Inc. (MAVP). Main Avenue is a New Jersey-headquartered pharmacy, which specializes in prescription topical creams. Main Avenue Pharmacy will now operate as a wholly-owned subsidiary of ScripsAmerica.
At the beginning of December, ScripsAmerica announced that it exercised an option to acquire 90 percent of PIMD International, LLC (PIMD). PIMD International is a Florida-headquartered pharmaceutical wholesaler that ScripsAmerica has had a working relationship with since Q4 2013.
Furthermore, this month, ScripsAmerica announced that its wholly-owned subsidiary, Main Avenue Pharmacy, reported $5,257,753 in approved orders during November 2014. This represents the third consecutive month that ScripsAmerica's specialty pharmacy generated more than $5 million in sales.
ScripsAmerica, Inc. (SCRC), closed Monday's trading session at $0.149, up 3.83%, on 1,048,225 volume with 146 trades. The average volume for the last 60 days is 357,521 and the stock's 52-week low/high is $0.0815/$0.21.
ScripsAmerica Inc. (SCRC)
Jan 17 2:40 PM EST
Last Price 0.1989
Last Trade 01/16/15
Change 0.0059
% Change 3.06%
Volume 271.42k
Open 0.195
High 0.1998
Low 0.19
52 Week Low 0.0815
52 Week High 0.213
more DD here
www.qualitystocks.net/quotedetail.php?qm_page=52488
http://www.qualitystocks.net/quotedetail.php?qm_page=52488
Mon, Jan 12, 2015
8:00 AM ScripsAmerica Launches Diabetes Patient Supply Program through Main Avenue Pharmacy - Accesswire
Mon, Jan 05, 2015
8:01 AM ScripsAmerica's Main Avenue Pharmacy Records $5.2 Million in Approved Orders for December 2014 - Accesswire
Tue, Dec 30, 2014
8:00 AM ScripsAmerica Pays Off $325,000 in High Interest Debt - Marketwired
Wed, Dec 10, 2014
4:05 PM ScripsAmerica Secures $4 Million Line of Credit From Triumph Healthcare Finance - Marketwired
Wed, Dec 03, 2014
2:48 PM ScripsAmerica's Specialty Pharmacy Records Over $5 Million in Approved Orders for the Third Consecutive Month - Marketwired
Tue, Dec 02, 2014
11:27 AM WSA Speaks to Three Companies on the Rise - Marketwired
11:27 AM WSA Speaks to Three Companies on the Rise - Marketwired
9:03 AM SeeThruEquity Initiates Research Coverage on ScripsAmerica with a Price Target of $1.20 - Accesswire
Mon, Dec 01, 2014
8:00 AM ScripsAmerica Exercises Option to Acquire 90% of PIMD International, LLC - Marketwired
Tue, Nov 25, 2014
8:00 AM ScripsAmerica Highlights CEO Interviews From Recent Investor Conference - Marketwired
Wed, Nov 19, 2014
8:00 AM ScripsAmerica Comments on Financial Results for the Third Quarter of 2014 - Marketwired
Tue, Nov 18, 2014
8:00 AM ScripsAmerica Announces Full Acquisition of Main Avenue Pharmacy - Marketwired
Mon, Nov 17, 2014
8:00 AM ScripsAmerica Announces Conference Call to Provide Business Update and Discuss Third Quarter Fiscal 2014 Results - Business Wire
Thu, Nov 13, 2014
1:39 PM "New To The Street" Is Back on the Street - Marketwired
Tue, Nov 04, 2014
8:00 AM ScripsAmerica Reports $5.6 Million in Approved Orders for Its Specialty Pharmacy in October - Marketwired
Tue, Oct 28, 2014
8:00 AM ScripsAmerica to Present at SeeThruEquity Microcap Investor Conference - Marketwired
Mon, Oct 06, 2014
8:00 AM ScripsAmerica's Specialty Pharmacy Reports $5.5 Million in Approved Orders for the Month of September - Marketwired
Tue, Sep 16, 2014
8:00 AM ScripsAmerica Expands Specialty Pharmacy Operations to Include 12 Additional States Through New Sourcing Agreement - Marketwired
Mon, Sep 08, 2014
8:00 AM ScripsAmerica Expands Specialty Pharmacy Operations Through Prescription Sourcing Agreement With United Apothecary, Inc. - Marketwired
Wed, Sep 03, 2014
8:00 AM ScripsAmerica's Specialty Pharmacy Continues Revenue Growth With $4.9 Million in Approved Orders for August - Marketwired
ScripsAmerica, Inc. is a supplier of prescription, Over-the-Counter (OTC), and nutraceutical drugs. The Tysons Corner, Virginia-based Company delivers pharmaceutical products to a wide assortment of end users across the health care industry by way of the largest pharmaceutical distributor in North America - McKesson Corp. End users include physicians' offices, retail pharmacies, long-term care sites, hospitals, and government and home care agencies. ScripsAmerica’s shares trade on the OTC Markets’ OTCQB.
The Company’s mission for consumers is to provide them the same high quality pharmaceutical, vitamin, and nutritional supplements that it supplies nationally to hospitals and nursing homes. It provides a strong low cost system of broad-based U.S. national marketing, sales, and distribution of generic Rx, branded Rx, OTC, nutraceuticals, and oral delivery OTC pharmaceuticals.
Regarding Pharmaceutical Contract Services, ScripsAmerica’s service offering includes fulfilling prescription and OTC orders, labeling, packaging, and shipping. Current therapeutic categories serviced by the Company include pain, arthritis, prenatal, urinary, and hormonal replacement drugs. The Company’s other customers include Cardinal Health, Curtis Pharmaceuticals, MedVet, as well as the United States Veterans Administration.
ScripsAmerica has its RapiMed® product line. RapiMed® is an inventive pharmaceutical and OTC oral delivery method employing “Quick Melt Technology”. RapiMed® oral tablets dissolve in 30 seconds or less. They provide fast delivery of medicine without water. ScripsAmerica holds the exclusive rights to RapiMed®.
Last month, ScripsAmerica announced that it recently acquired 100 percent of Main Avenue Pharmacy, Inc. (MAVP). Main Avenue is a New Jersey-headquartered pharmacy, which specializes in prescription topical creams. Main Avenue Pharmacy will now operate as a wholly-owned subsidiary of ScripsAmerica.
At the beginning of December, ScripsAmerica announced that it exercised an option to acquire 90 percent of PIMD International, LLC (PIMD). PIMD International is a Florida-headquartered pharmaceutical wholesaler that ScripsAmerica has had a working relationship with since Q4 2013.
Furthermore, this month, ScripsAmerica announced that its wholly-owned subsidiary, Main Avenue Pharmacy, reported $5,257,753 in approved orders during November 2014. This represents the third consecutive month that ScripsAmerica's specialty pharmacy generated more than $5 million in sales.
ScripsAmerica, Inc. (SCRC), closed Monday's trading session at $0.149, up 3.83%, on 1,048,225 volume with 146 trades. The average volume for the last 60 days is 357,521 and the stock's 52-week low/high is $0.0815/$0.21.
ScripsAmerica Inc. (SCRC)
Jan 17 2:40 PM EST
Last Price 0.1989
Last Trade 01/16/15
Change 0.0059
% Change 3.06%
Volume 271.42k
Open 0.195
High 0.1998
Low 0.19
52 Week Low 0.0815
52 Week High 0.213
more DD here
www.qualitystocks.net/quotedetail.php?qm_page=52488
http://www.qualitystocks.net/quotedetail.php?qm_page=52488
Mon, Jan 12, 2015
8:00 AM ScripsAmerica Launches Diabetes Patient Supply Program through Main Avenue Pharmacy - Accesswire
Mon, Jan 05, 2015
8:01 AM ScripsAmerica's Main Avenue Pharmacy Records $5.2 Million in Approved Orders for December 2014 - Accesswire
Tue, Dec 30, 2014
8:00 AM ScripsAmerica Pays Off $325,000 in High Interest Debt - Marketwired
Wed, Dec 10, 2014
4:05 PM ScripsAmerica Secures $4 Million Line of Credit From Triumph Healthcare Finance - Marketwired
Wed, Dec 03, 2014
2:48 PM ScripsAmerica's Specialty Pharmacy Records Over $5 Million in Approved Orders for the Third Consecutive Month - Marketwired
Tue, Dec 02, 2014
11:27 AM WSA Speaks to Three Companies on the Rise - Marketwired
11:27 AM WSA Speaks to Three Companies on the Rise - Marketwired
9:03 AM SeeThruEquity Initiates Research Coverage on ScripsAmerica with a Price Target of $1.20 - Accesswire
Mon, Dec 01, 2014
8:00 AM ScripsAmerica Exercises Option to Acquire 90% of PIMD International, LLC - Marketwired
Tue, Nov 25, 2014
8:00 AM ScripsAmerica Highlights CEO Interviews From Recent Investor Conference - Marketwired
Wed, Nov 19, 2014
8:00 AM ScripsAmerica Comments on Financial Results for the Third Quarter of 2014 - Marketwired
Tue, Nov 18, 2014
8:00 AM ScripsAmerica Announces Full Acquisition of Main Avenue Pharmacy - Marketwired
Mon, Nov 17, 2014
8:00 AM ScripsAmerica Announces Conference Call to Provide Business Update and Discuss Third Quarter Fiscal 2014 Results - Business Wire
Thu, Nov 13, 2014
1:39 PM "New To The Street" Is Back on the Street - Marketwired
Tue, Nov 04, 2014
8:00 AM ScripsAmerica Reports $5.6 Million in Approved Orders for Its Specialty Pharmacy in October - Marketwired
Tue, Oct 28, 2014
8:00 AM ScripsAmerica to Present at SeeThruEquity Microcap Investor Conference - Marketwired
Mon, Oct 06, 2014
8:00 AM ScripsAmerica's Specialty Pharmacy Reports $5.5 Million in Approved Orders for the Month of September - Marketwired
Tue, Sep 16, 2014
8:00 AM ScripsAmerica Expands Specialty Pharmacy Operations to Include 12 Additional States Through New Sourcing Agreement - Marketwired
Mon, Sep 08, 2014
8:00 AM ScripsAmerica Expands Specialty Pharmacy Operations Through Prescription Sourcing Agreement With United Apothecary, Inc. - Marketwired
Wed, Sep 03, 2014
8:00 AM ScripsAmerica's Specialty Pharmacy Continues Revenue Growth With $4.9 Million in Approved Orders for August - Marketwired
(0)
(0)